Atlas Trials

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

Clinical trial NCT06842056 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06842056
Sponsor
AstraZeneca
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2027-04-01
Primary completion
2030-03-31
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.